We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress
Sign In
Advertise with Us
LGC Clinical Diagnostics

Download Mobile App




Beyond Brazil, Latin American IVD Sector Grows

By LabMedica International staff writers
Posted on 19 Apr 2015
Print article
A new healthcare market analysis finds that in addition to Brazil, there are smaller countries in Latin America that are also top targets for in vitro diagnostics (IVD) firms as their IVD sectors are projected to grow at faster rates.

Kalorama Information (New York, NY, USA) said that Brazil figures heavily into IVD strategies for the Latin American continent with a population of over 200 million people and industry to support globally distributed supply operations. However, Brazil’s regional economic clout may not ensure its status as a leading target IVD expansion market. According to Kalorama’s latest projections for Latin American IVD, the less competitive markets of Chile, Colombia, and Peru are expected to grow by faster rates through 2019 while outpacing growth for Latin American IVD as a whole. While Brazil can claim preeminence in terms of scale, these and other factors have made other South American markets increasingly relevant to global IVD expansion.

The findings were made in Kalorama’s new report: The Market for In Vitro Diagnostic Tests in Latin America (Colombia, Brazil, Peru, Argentina, Chile, Venezuela, Ecuador, and Other Nations).

“In six years, Colombia, Peru, and Chile combined will represent an IVD market that is 60% of the size of Brazil’s despite the combined national populations being less than half the Brazilian population,” said Bruce Carlson, publisher of Kalorama Information. Macroeconomic forces have quickly altered the market landscape in Latin America. Slackened economic growth has negated previously explosive prospects for Brazil’s market, while reform and economic investment have increased health spending in peripheral countries.

Kalorama cites 3 countries as having above-average opportunity.

Columbia, the second most populous South American country, is emblematic of the emerging opportunities for global IVD. Colombia is sufficiently urbanized, at roughly 75% of the total population, to support effective distribution and access. With economic diversification and newfound wealth, Colombia has begun to improve its near-universal healthcare system established with the 1991 constitution. Consumption expenditure growth has roughly matched recent GDP growth at 4%–7% annually.

Peru is in a period of marked economic improvement, with the IMF designating it a leading Latin American economy and destination for investment. Recent sustained economic growth has been possible through the inauguration of political stability in the beginning of the century. Despite an invigorated economy, Peru still suffers from widespread poverty among anywhere from 30% to 50% of the national population of 30 million. While healthcare coverage has improved, the Peruvian system depends on private expenditures—largely out-of-pocket— for approximately 2/3 of total healthcare spending. Peru has approximately 1,300 clinical labs. While featuring a less developed healthcare system, Peru has seen significant growth in demand over the past decade and is projected to lead Latin American in IVD growth through 2019.

In Chile, the current administration has sought to address its relatively high income inequality among developed (OECD) countries by implementing welfare programs and improving its Universal Access with Explicit Guarantees (AUGE or GES) program. Nearly universal healthcare coverage is provided to Chileans through both a public insurer (FONASA) covering 75% of the population and group of regulated, private insurers. FONASA guarantees coverage for specific health issues; additional, heavily subsidized care was recently made available to the elderly. Despite moves made to improve the effectiveness of public care following privatization under Pinochet, the level of care remains significantly higher in the Chilean private healthcare sector.

Related Links:

Kalorama Information
The Market for In Vitro Diagnostic Tests in Latin America, report
IVD in Mexico

Platinum Member
COVID-19 Rapid Test
OSOM COVID-19 Antigen Rapid Test
One Step HbA1c Measuring System
GREENCARE A1c
Complement 3 (C3) Test
GPP-100 C3 Kit
Gold Member
Real-time PCR System
GentierX3 Series

Print article

Channels

Clinical Chemistry

view channel
Image: Reaching speeds up to 6,000 RPM, this centrifuge forms the basis for a new type of inexpensive, POC biomedical test (Photo courtesy of Duke University)

POC Biomedical Test Spins Water Droplet Using Sound Waves for Cancer Detection

Exosomes, tiny cellular bioparticles carrying a specific set of proteins, lipids, and genetic materials, play a crucial role in cell communication and hold promise for non-invasive diagnostics.... Read more

Molecular Diagnostics

view channel
Image: The study showed the blood-based cancer screening test detects 83% of people with colorectal cancer with specificity of 90% (Photo courtesy of Guardant Health)

Blood Test Shows 83% Accuracy for Detecting Colorectal Cancer

Colorectal cancer is the second biggest cause of cancer deaths among adults in the U.S., with forecasts suggesting 53,010 people might die from it in 2024. While fewer older adults are dying from this... Read more

Hematology

view channel
Image: The Gazelle Hb Variant Test (Photo courtesy of Hemex Health)

First Affordable and Rapid Test for Beta Thalassemia Demonstrates 99% Diagnostic Accuracy

Hemoglobin disorders rank as some of the most prevalent monogenic diseases globally. Among various hemoglobin disorders, beta thalassemia, a hereditary blood disorder, affects about 1.5% of the world's... Read more

Microbiology

view channel
Image: The new platform is designed to perform blood-based diagnoses of nontuberculosis mycobacteria (Photo courtesy of 123RF)

New Blood Test Cuts Diagnosis Time for Nontuberculous Mycobacteria Infections from Months to Hours

Breathing in nontuberculous mycobacteria (NTM) is a common experience for many people. These bacteria are present in water systems, soil, and dust all over the world and usually don't cause any problems.... Read more
Copyright © 2000-2024 Globetech Media. All rights reserved.